Covid-19: Dr Reddy's, Cipla, 3 more pharma firms partner for clinical trial of oral anti-viral drug
- The five pharma companies have entered into a collaboration agreement, wherein the parties will jointly sponsor, supervise and monitor the clinical trial in India
Indian pharma majors including Dr Reddy's Laboratories and Sun Pharma have collaborated for clinical trial of investigational oral anti-viral drug Molnupiravir for Covid-19. The five companies: Cipla, Dr Reddy's, Emcure, Sun Pharma and Torrent Pharma announced on Tuesday that they will collaborate for the clinical trial of the investigational oral anti-viral drug Molnupiravir for the treatment of mild Covid-19 in an outpatient setting in India.
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more